Lv42
690 积分 2023-02-28 加入
Eosinophil-induced adverse events induced by treatment with programmed cell death 1/ligand 1 inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system
6小时前
待确认
Adverse cardiovascular events in rheumatoid arthritis patients treated with JAK inhibitors: An analysis of postmarketing spontaneous safety reports
1天前
待确认
Analysis of Immune-Related Adverse Events of Pembrolizumab Using FAERS Database
1天前
求助中
The real-world safety profile of sertraline: Pharmacovigilance analysis of the FAERS database
4天前
已完结
Gastrointestinal adverse events associated with SNRIs: A FAERS-based pharmacovigilance study
4天前
已完结
A disproportionality analysis of nervous system adverse events associated with disease-modifying therapies in multiple sclerosis: insights from the FDA adverse event reporting system (FAERS)
5天前
已完结
Depression and suicide/self-injury signals for weight loss medications: A disproportionality analysis of semaglutide, liraglutide, and tirzepatide in FAERS database
5天前
已完结
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)
5天前
已完结
Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis
12天前
已完结
Exploring the Risk of Adverse Drug Events in Combination with antiparkinsonics and antipsychotics - a two-decade real-world pharmacovigilance analysis based on the FAERS database
14天前
已完结
皖公网安备34019202002308
